NCT06943495
- Conditions
- Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Locations
-
- CHU de Québec-Université Laval Québec, Quebec, Canada
Clinical trial condition
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Explore clinical trials studying Metastatic Castrate Resistant Prostate Cancer (mCRPC). Study availability and eligibility vary by location and protocol.
9 public trials
2 recruiting studies
Metastatic Castrate Resistant Prostate Cancer (mCRPC) trial results
NCT06720532
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Disease, +6 more
- Locations
-
- Klinikum rechts der Isar, München, Bavaria 81675 Munich, Germany
Not Yet Recruiting
A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
NCT07592910
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
NCT07090369
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT03899467
- Conditions
- Metastatic Castrate Resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- University Cancer & Blood Center Athens, Georgia, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Chesapeake Urology Research Associates Towson, Maryland, United States
- G U Research Network Omaha, Nebraska, United States
NCT02826772
- Conditions
- Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Locations
-
- Chesapeake Urology Research Associates Towson, Maryland, United States
- G U Research Network Omaha, Nebraska, United States
- Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
- Rutgers University New Brunswick, New Jersey, United States
NCT04597125
- Conditions
- Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Locations
-
- Specialist Services Medical Group Castle Hill, New South Wales, Australia
- Gosford Hospital Gosford, New South Wales, Australia
- Nepean Hospital Kingswood, New South Wales, Australia
- North West Cancer Centre North Tamworth, New South Wales, Australia
Active, Not Recruiting
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324
- Conditions
- Disease Attributes, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Urology Centers of Alabama Homewood, Alabama, United States
- Ironwood Cancer & Research Centers Chandler, Arizona, United States
- Ironwood Cancer & Research Centers Gilbert, Arizona, United States
- Ironwood Cancer & Research Centers Glendale, Arizona, United States
Active, Not Recruiting
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07214961
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
- Locations
-
- BAMF Health Grand Rapids, Michigan, United States
- XCancer Omaha, Nebraska, United States
- United Theranostics Princeton, New Jersey, United States